Sanjivani Paranteral Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 328426,
    "name": "Sanjiv.Parant.",
    "stock_name": "Sanjiv.Parant.",
    "full_name": "Sanjivani Paranteral Ltd",
    "name_url": "stocks-analysis/sanjivparant",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "149.90",
    "chg": 6.15,
    "chgp": "4.28%",
    "dir": 1,
    "prev_price": "143.75",
    "mcapval": "184.14 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531569,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE860D01013",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "5.71 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/sanjivparant-328426-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sanjivani Paranteral Ltd Falls to 52-Week Low of Rs 126 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-stock-hits-52-week-low-at-rs126-4002482",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SanjivaniParant_priceRelatedfactors_4002482.png",
        "date": "2026-05-21 09:46:42",
        "description": "A sharp decline has pushed Sanjivani Paranteral Ltd to a fresh 52-week low of Rs 126 on 21 May 2026, marking a 41.44% drop over the past year, significantly underperforming the Sensex's 7.27% decline during the same period."
      },
      {
        "title": "Sanjivani Paranteral Ltd Falls to 52-Week Low of Rs 126 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-stock-falls-to-52-week-low-of-rs126-4002477",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SanjivaniParant_priceRelatedfactors_4002477.png",
        "date": "2026-05-21 09:46:41",
        "description": "A sustained decline has pushed Sanjivani Paranteral Ltd to a fresh 52-week low of Rs 126 on 21 May 2026, marking a 41.44% drop over the past year, significantly underperforming the Sensex’s 7.27% decline in the same period."
      },
      {
        "title": "Sanjivani Paranteral Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-valuation-shifts-signal-renewed-price-attractiveness-3988403",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SanjivaniParant_valuationdot_3988403.png",
        "date": "2026-05-13 08:00:24",
        "description": "Sanjivani Paranteral Ltd has witnessed a notable shift in its valuation parameters, moving from a previously fair valuation to an attractive one, as reflected in its updated price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This change, coupled with a recent upgrade in its Mojo Grade from Sell to Hold, suggests a recalibration of market sentiment towards the pharmaceuticals and biotechnology micro-cap, despite recent price volatility and underperformance relative to the Sensex."
      },
      {
        "title": "When is the next results date for Sanjivani Paranteral Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-sanjivani-paranteral-ltd-3978464",
        "imagepath": "",
        "date": "2026-05-06 23:16:06",
        "description": "The next results date for Sanjivani Paranteral Ltd is scheduled for 14 May 2026...."
      },
      {
        "title": "Sanjivani Paranteral Ltd Downgraded to Sell Amid Bearish Technicals and Market Underperformance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-downgraded-to-sell-amid-bearish-technicals-and-market-underperformance-3955037",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SanjivaniParant_mojoScore_3955037.png",
        "date": "2026-04-21 08:03:08",
        "description": "Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 20 Apr 2026. This decision follows a comprehensive reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals. Despite some positive long-term growth indicators, the stock’s recent performance and technical signals have raised concerns among analysts, prompting a cautious stance."
      },
      {
        "title": "Sanjivani Paranteral Ltd Gains 6.20%: Technical Upgrade and Valuation Shift Drive Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-gains-620-technical-upgrade-and-valuation-shift-drive-momentum-3952794",
        "imagepath": "",
        "date": "2026-04-19 09:00:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Apr:</strong> Stock opens at Rs.167.00, declines 1.45%</p>\n                    <p><strong>15 Apr:</strong> Sharp rally to Rs.181.40 (+8.62%) following rating upgrade</p>\n                    <p><strong>16 Apr:</strong> Valuation shifts to expensive amid strong price rally</p>\n                    <p><strong>17 Apr:</strong> Week closes at Rs.179.95, marginal decline of 0.14%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.167.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.179...."
      },
      {
        "title": "Sanjivani Paranteral Ltd Upgraded to Hold by MarketsMOJO on Technical Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-upgraded-to-hold-by-marketsmojo-on-technical-improvements-3948216",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SanjivaniParant_mojoScore_3948216.png",
        "date": "2026-04-16 08:02:53",
        "description": "Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 15 Apr 2026. This shift reflects nuanced changes across four key parameters: quality, valuation, financial trend, and technicals. Despite a challenging year marked by underperformance relative to the broader market, the company’s improving fundamentals and technical indicators have prompted a reassessment of its outlook."
      },
      {
        "title": "Sanjivani Paranteral Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-valuation-shifts-signal-changing-market-sentiment-3947997",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SanjivaniParant_valuationdot_3947997.png",
        "date": "2026-04-16 08:00:23",
        "description": "Sanjivani Paranteral Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating amid a recent surge in its share price. This change reflects evolving market perceptions in the Pharmaceuticals & Biotechnology sector, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now exceeding historical and peer averages. Investors are weighing these valuation adjustments against the company’s financial performance and sector dynamics to reassess its attractiveness."
      },
      {
        "title": "Sanjivani Paranteral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-sell-3944501",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SanjivaniParant_mojoScore_3944501.png",
        "date": "2026-04-13 10:10:45",
        "description": "Sanjivani Paranteral Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 15,
    "sid": "328426",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/sanjivani-paranteral-328426"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "11-Jun-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ashwani Khemka",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "29-May-2026",
      "details": "Annual Secretarial Compliance Report for the financial year ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 21St May 2026",
      "datetime": "21-May-2026",
      "details": "Dear Sir/Madam Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Thursday 21st May 2026 inter alia considered and approved the appointment of Mr. Bhavesh M. Rathod Chartered Accountants Registered Valuer for carrying out valuation and determination of issue price of the proposed warrants to be issued by way of preferential issue",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sanjivani Paranteral Ltd has declared <strong>5%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sanjivani Paranteral Ltd Falls to 52-Week Low of Rs 126 as Sell-Off Deepens

2026-05-21 09:46:42

A sharp decline has pushed Sanjivani Paranteral Ltd to a fresh 52-week low of Rs 126 on 21 May 2026, marking a 41.44% drop over the past year, significantly underperforming the Sensex's 7.27% decline during the same period.

Sanjivani Paranteral Ltd Falls to 52-Week Low of Rs 126 Amidst Prolonged Downtrend

2026-05-21 09:46:41

A sustained decline has pushed Sanjivani Paranteral Ltd to a fresh 52-week low of Rs 126 on 21 May 2026, marking a 41.44% drop over the past year, significantly underperforming the Sensex’s 7.27% decline in the same period.

Sanjivani Paranteral Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-05-13 08:00:24

Sanjivani Paranteral Ltd has witnessed a notable shift in its valuation parameters, moving from a previously fair valuation to an attractive one, as reflected in its updated price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This change, coupled with a recent upgrade in its Mojo Grade from Sell to Hold, suggests a recalibration of market sentiment towards the pharmaceuticals and biotechnology micro-cap, despite recent price volatility and underperformance relative to the Sensex.

When is the next results date for Sanjivani Paranteral Ltd?

2026-05-06 23:16:06

The next results date for Sanjivani Paranteral Ltd is scheduled for 14 May 2026....

Sanjivani Paranteral Ltd Downgraded to Sell Amid Bearish Technicals and Market Underperformance

2026-04-21 08:03:08

Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 20 Apr 2026. This decision follows a comprehensive reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals. Despite some positive long-term growth indicators, the stock’s recent performance and technical signals have raised concerns among analysts, prompting a cautious stance.

Sanjivani Paranteral Ltd Gains 6.20%: Technical Upgrade and Valuation Shift Drive Momentum

2026-04-19 09:00:41

Key Events This Week 13 Apr: Stock opens at Rs.167.00, declines 1.45% 15 Apr: Sharp rally to Rs.181.40 (+8.62%) following rating upgrade 16 Apr: Valuation shifts to expensive amid strong price rally 17 Apr: Week closes at Rs.179.95, marginal decline of 0.14% Week OpenRs.167.00 Week CloseRs.179....

Sanjivani Paranteral Ltd Upgraded to Hold by MarketsMOJO on Technical Improvements

2026-04-16 08:02:53

Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 15 Apr 2026. This shift reflects nuanced changes across four key parameters: quality, valuation, financial trend, and technicals. Despite a challenging year marked by underperformance relative to the broader market, the company’s improving fundamentals and technical indicators have prompted a reassessment of its outlook.

Sanjivani Paranteral Ltd Valuation Shifts Signal Changing Market Sentiment

2026-04-16 08:00:23

Sanjivani Paranteral Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating amid a recent surge in its share price. This change reflects evolving market perceptions in the Pharmaceuticals & Biotechnology sector, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now exceeding historical and peer averages. Investors are weighing these valuation adjustments against the company’s financial performance and sector dynamics to reassess its attractiveness.

Sanjivani Paranteral Ltd is Rated Sell

2026-04-13 10:10:45

Sanjivani Paranteral Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 April 2026, providing investors with the latest insights into the company’s performance and outlook.

View All News